Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
about
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsCUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesAutoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinomaAutoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Development of a multiplex autoantibody test for detection of lung cancerStudy of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancerCirculating antibodies to p16 protein-derived peptides in breast cancerStudy of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.Further study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancerUsing immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell CarcinomaTargeting the MHC Class II antigen presentation pathway in cancer immunotherapy.Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer.Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.Autoimmunity and Gastric Cancer.Tumor-associated auto-antibodies as early detection markers for ovarian cancer? A prospective evaluation.Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.A study of circulating anti-CD25 antibodies in non-small cell lung cancer.Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
P2860
Q26750672-FA9C60E5-021A-4258-96C4-9F92C3335EF3Q26999045-406EFBAB-BB2F-4CBA-809B-143F0151DF20Q33648667-D3236982-F38C-4E73-AE2E-6C7133B3D8CFQ33895872-AA9BA44C-965B-4140-89D8-95DE52197230Q34049184-870AEA6E-8243-43A8-80AD-79A4BAC4DC45Q35154906-52EC2F49-53B4-4388-A77C-08EC9B617417Q35244082-15B364EF-E24B-4844-9B98-2B95801E3407Q35753707-B679E2C9-E995-4E16-A643-5E70993710B7Q36146042-4A497705-6966-4C11-B61A-E0B1A3DF5159Q36694379-22F0627C-D69F-44A8-ABD2-ADEB56DA7744Q37213540-561327C5-93B7-4DC3-9A54-00A9B7EA21B0Q37681008-E4DA8095-5694-447C-ABBE-15D8160614ADQ38060734-5720DE9E-E904-44A1-BAE5-49AD136EA8D9Q38167718-2BAD45CA-79D1-43B7-9878-E59120390442Q38981242-2FF42605-2EB8-43CF-A560-0AF83A3BB125Q41491324-E7DA75F8-AD60-4B52-A825-70F674814A59Q43818115-93E663C2-D51E-407C-B3E2-F111E06669DBQ47664450-8E2E65ED-C763-48EC-BA1C-7CD6F7CCE839Q49419816-F5CC6066-FE86-4852-A7A3-1C70FFD104FAQ49652793-21924DCF-7288-4645-B18F-A42F8154A1E8Q50145937-477C758B-F83F-4272-9954-67C849F9261EQ51331951-69D679FE-4AB5-4ABB-BB5D-76D1EB772E9DQ53052268-6C109430-9AF7-46E3-8803-A7500C9623C7Q54250692-2634931F-AED1-42C0-BAD6-FF3F94B1A21BQ54382756-6D8FBB14-956B-4124-8286-3A36F48D7706
P2860
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@ast
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@en
type
label
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@ast
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@en
prefLabel
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@ast
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@en
P2093
P2860
P1433
P1476
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
@en
P2093
P2860
P304
P356
10.1016/J.AUTREV.2010.12.002
P577
2010-12-15T00:00:00Z